Table 3.

Hazard Ratios for the Development of T2DM (Endpoint Ad)

	HR	95% CI	P Value
BMI	1.073	1.014–1.136	0.015
HbA1c	19.907	12.311–32.189	<0.001
Total cholesterol	0.998	0.993–1.004	NS
Cr	0.105	0.022–0.512	0.005
UA	0.909	0.780–1.059	NS
Endpoint Ad >5.2 μg/mL subgroup	0.274	0.149–0.503	<0.001
Stepwise backward selection procedure
HbA1c	19.662	12.195–31.702	<0.001
BMI	1.062	1.007–1.121	0.026
Cr	0.087	0.018–0.410	0.002
Endpoint Ad >5.2 μg/mL subgroup	0.275	0.150–0.504	<0.001

Abbreviation: NS, not significant.